PASSAGE BIO, INC. (PASG) Operating income 2019–2025
PASSAGE BIO, INC. (PASG) annual operating income history from SEC filings — each fiscal year as reported.
-$49.3MFY2025 · since FY2019: -$37.2M → -$49.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.3M | +30.0% |
| FY2024 | -$70.4M | +35.0% |
| FY2023 | -$108.4M | +21.7% |
| FY2022 | -$138.4M | +25.5% |
| FY2021 | -$185.7M | -64.5% |
| FY2020 | -$112.9M | -203.6% |
| FY2019 | -$37.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PASG financial trends
PASG RevenuePASG Net incomePASG Net marginPASG Gross profitPASG Gross marginPASG Operating marginPASG Operating cash flowPASG Free cash flowPASG Capital expendituresPASG Return on equityPASG Stock buybacksPASG Dividends paidPASG Total assetsPASG Total liabilitiesPASG Shareholders’ equityPASG overview →